Identification of genes associated to 2′,2′- difluorodeoxycytidine resistance in HeLa cells with a lentiviral short-hairpin RNA library

Biochemical Pharmacology

Volumn 82, Issue 3, 2011, Pages 210-215

  Xu, Yunjian ^a   Karlsson, Anna ^a   Johansson, Magnus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chemotherapy; Drug resistance; Nucleoside analog; RNA interference; Short hairpin RNA; Small interfering RNA

Indexed keywords

CELL PROTEIN; GEMCITABINE; LENTIVIRUS VECTOR; SERINE ARGININE RICH SPLICING FACTOR 3; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; SPLICING FACTOR PROLINE GLUTAMINE RICH; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA SEQUENCE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE LIBRARY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

ANTIMETABOLITES, ANTINEOPLASTIC; BASE SEQUENCE; CELL PROLIFERATION; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; GENE LIBRARY; HELA CELLS; HUMANS; RNA, SMALL INTERFERING; RNA, VIRAL;

EID: 79959573283     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.04.012     Document Type: Article

References (27)

1. A. Wong, R.A. Soo, W.P. Yong, and F. Innocenti Clinical pharmacology and pharmacogenetics of gemcitabine Drug Metab Rev 41 2009 77 88
2. J.R. Mackey, R.S. Mani, M. Selner, D. Mowles, J.D. Young, and J.A. Belt Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines Cancer Res 58 1988 4349 4357
3. V. Heinemann, L.W. Hertel, G.B. Grindey, and W. Plunkett Comparison of the cellular pharmacokinetics and toxicity of 2′,2′- difluorodeoxycytidine and 1-beta-d-arabinofuranosylcytosine Cancer Res 48 1988 4024 4031
4. P. Huang, S. Chubb, L.W. Hertel, G.B. Grindey, and W. Plunkett Action of 2′,2′-difluorodeoxycytidine on DNA synthesis Cancer Res 51 1991 6110 6117
5. V. Heinemann, Y.Z. Xu, S. Chubb, A. Sen, L.W. Hertel, and G.B. Grindey Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′- difluorodeoxycytidine Mol Pharmacol 38 1990 567 572 (Pubitemid 20356209)
6. P. Pourquier, C. Gioffre, G. Kohlhagen, Y. Urasaki, F. Goldwasser, and L.W. Hertel Gemcitabine (2′,2′-difluoro-2′-deoxycytidine), an antimetabolite that poisons topoisomerase I Clin Cancer Res 8 2002 2499 2504 (Pubitemid 34856331)
7. R. Bernards, T.R. Brummelkamp, and R.L. Beijersbergen shRNA libraries and their use in cancer genetics Nat Methods 3 2006 701 706 (Pubitemid 44275737)
8. Y. Sun, Y. Fang, M.S. Yoon, C. Zhang, M. Roccio, and F.J. Zwartkruis Phospholipase D1 is an effector of Rheb in the mTOR pathway Proc Natl Acad Sci USA 105 2008 8286 8291 (Pubitemid 351904748)
9. S.H. Wimmer-Kleikamp, E. Nievergall, K. Gegenbauer, S. Adikari, M. Mansour, and T. Yeadon Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells Blood 112 2008 721 732
10. M. Yamashita, M. Kuwahara, A. Suzuki, K. Hirahara, R. Shinnaksu, and H. Hosokawa Bmi1 regulates memory CD4 T cell survival via repression of the Noxa gene J Exp Med 205 2008 1109 1120 (Pubitemid 351679686)
11. K. Berns, E.M. Hijmans, J. Mullenders, T.R. Brummelkamp, A. Velds, and M. Heimerikx A large-scale RNAi screen in human cells identifies new components of the p53 pathway Nature 428 2004 431 437 (Pubitemid 38419689)
12. P.J. Paddison, J.M. Silva, D.S. Conklin, M. Schlabach, M. Li, and S. Aruleba A resource for large-scale RNA-interference-based screens in mammals Nature 428 2004 427 431 (Pubitemid 38419688)
13. L. Zheng, J. Liu, S. Batalov, D. Zhou, A. Orth, and S. Ding An approach to genome wide screens of expressed small interfering RNAs in mammalian cells Proc Natl Acad Sci USA 101 2004 135 140 (Pubitemid 38084216)
14. D.E. Root, N. Hacohen, W.C. Hahn, E.S. Lander, and D.M. Sabatini Genome-scale loss-of-function screening with a lentiviral library Nat Methods 3 2006 715 718
15. Z. Duan, E.J. Weinstein, D. Ji, R.Y. Ames, E. Choy, and H. Mankin Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer Mol Cancer Ther 7 2008 2377 2385
16. J. Moffat, D.A. Grueneberg, X. Yang, S.Y. Kim, A.M. Kloepfer, and G. Hinkle A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen Cell 124 2006 1283 1298
17. R.I. Freshney Culture of animal cells: a manual of basic technique 5th ed. 2005 Wiley-Liss Wilmington, DE
18. N.A. Franken, H.M. Rodermond, J. Stap, J. Haveman, and C. van Bree Clonogenic assay of cells in vitro Nat Protoc 1 2006 2315 2319
19. B.J. Blencowe, J.A. Bowman, S. McCracken, and E. Rosonina SR-related proteins and the processing of messenger RNA precursors Biochem Cell Biol 77 1999 277 291 (Pubitemid 29531851)
20. J.G. Patton, E.B. Porro, J. Galceran, P. Tempst, and B. Nadal-Ginard Cloning and characterization of PSF, a novel pre-mRNA splicing factor Genes Dev 7 1993 393 406 (Pubitemid 23139233)
21. O. Gozani, J.G. Patton, and R. Reed A novel set of spliceosome-associated proteins and the essential splicing factor PSF bind stably to pre-mRNA prior to catalytic step II of the splicing reaction EMBO J 13 1994 3356 3367
22. R. Peng, I. Hawkins, A.J. Link, and J.G. Patton The splicing factor PSF is part of a large complex that assembles in the absence of pre-mRNA and contains all five snRNPs RNA Biol 3 2006 69 76 (Pubitemid 44444597)
23. C. Rajesh, D.K. Baker, A.J. Pierce, and D.L. Pittman The splicing-factor related protein SFPQ/PSF interacts with RAD51D and is necessary for homology-directed repair and sister chromatid cohesion Nucleic Acids Res 39 2011 132 145
24. M. Salton, Y. Lerenthal, S.Y. Wang, D.J. Chen, and Y. Shiloh Involvement of matrin 3 and SFPQ/NONO in the DNA damage response Cell Cycle 9 2010 1568 1576
25. X. He, A.D. Arslan, M.D. Pool, T.T. Ho, K.M. Darcy, and J.S. Coon Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer Oncogene 30 2011 356 365
26. L. Li, B. Fridley, K. Kalari, G. Jenkins, A. Batzler, and S. Safgren Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression Cancer Res 68 2008 7050 7058
27. L. Li, B.L. Fridley, K. Kalari, G. Jenkins, A. Batzler, and R.M. Weinshilboum Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers PLoS One 4 2009 e7765